Latest Breaking News On - Genscript asia pacific - Page 1 : comparemela.com

Genscript Singapore s Open Day Reveals Pioneering AI Capabilities In Recombinant Protein Production And Drug Discovery

Genscript Singapore s Open Day Reveals Pioneering AI Capabilities In Recombinant Protein Production And Drug Discovery
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyCassie yapJanice jinPrnewswire genscriptGenscript asia pacificGenscript biotech corporationOpen dayPatent numberPopulation immune algorithmGenscript asiaScript biotech corporationGenscript biotechScript biotech

GenScript Singapore s Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery

GenScript Singapore s Open Day Reveals Pioneering AI Capabilities in Recombinant Protein Production and Drug Discovery
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesNew jerseyJanice jinPrnewswire genscriptCassie yapGenscript asia pacificGenscript biotech corporationRecombinant protein productionOpen dayCodon optimizationPatent numberPopulation immune algorithmGenscript asiaScript biotech corporationGenscript biotechScript biotech

GenScript Partners with Allozymes to Accelerate Protein Discovery and Target Identification

/PRNewswire/ GenScript Biotech Corporation, the world s leading provider of life-science research tools and services, is partnering with Allozymes, a.

United statesHong kongNew jerseyPeyman salehianGenscript asia pacificTim coxHong kong stock exchangePrecision mutant libraryGenscript biotech corporationScript biotech corporationMutant libraryDawn leeGenscript asiaGenscript biotechScript biotechMainland china

GenScript takes home Executive of the Year - Biotechnology at the SBR Management Excellence Awards 2022

Mr. Johnson Wang has propelled the GenScript APAC team to achieve numerous milestones despite external challenges. SINGAPORE, Nov. 18, 2022 /PRNewswire/ Global biotechnology corporation, GenScript Asia Pacific's President, Mr. Johnson Wang bagged the Executive of the Year - Biotechnology title at the recently held SBR Management Excellence Awards 2022 for his dedication to building up GenScript Asia Pacific team since 2019. The prestigious awards honor individuals or teams that have made a huge contribution to the companies' success and Singapore's growth. Mr. Johnson Wang receiving the Executive of The Year in Biotechnology category Award "I'm deeply honored to receive this award from the Singapore Business Review team and this wouldn't have happened without the dedication of our team members who have worked tirelessly to make the company one of the most recognized biotechnology brands globally today. I would also like to thank our stakeholders and key partn

Hong kongNew jerseyUnited statesJohnson wangGenscript asia pacificHong kong stock exchangeGenscript biotech corporationExcellence awardsSingapore business reviewScript biotechScript asia pacificAsia pacificScript biotech corporationGenscript biotechMainland chinaMr johnson wang has propelled the genscript apac team to achieve numerous milestones despite external challenges singapore

GenScript Supported Nasal Spray Development for COVID-19 Protection with GMP-grade Antibodies and Subsequently Planned for Long-Term Collaboration with Biogenexis

SINGAPORE, Nov. 1, 2022 /PRNewswire/ GenScript Biotech Corporation ("GenScript", Stock Code: 1548.HK), a leading global biotechnology company supported Chulalongkorn University, a research-intensive university in Thailand in developing human anti-SARS-CoV-2 antibodies with antibody production and characterization services. The antibodies were licensed to Hibiocy Co. Ltd., which further developed them into a nasal spray medical device named VAILL COVITRAP. The Thai FDA has approved VAILL COVITRAP as a Class 4 medical device, making Thailand the first country to approve the manufacturing of human monoclonal antibody-based COVID-19 nasal spray. The human anti-SARS-CoV-2 antibodies which area crucial part ofthe VAILL COVITRAP nasal spray device weredeveloped by Dr. Trairak Pisitkun's team from Chulalongkorn University, Bangkok, Thailand. GenScript has supported the team with antibody production and characterization during the early phase of research and contributed to the d

Hong kongNew jerseyUnited statesKrung thep mahanakhonJohnson wangTrairak pisitkunGenscript asia pacificHibiocy coHong kong stock exchangePrnewswire genscript biotech corporationChulalongkorn universityGenscript biotech corporationScript biotech corporationStock codeGenscript asiaGenscript biotech